About Genexa
Genexa is a Healthcare company based in Beverly Hills (United States) founded in 2014 by David Johnson. Nutraceutical products for health concerns are manufactured in various forms. Genexa has raised $60 million across 2 funding rounds from investors including North Castle Partners, Nikki Reed and Platinum Mile Ventures. The company has 23 employees. Its chief executive, as recorded, is David Johnson. Its website genexa.com draws about 43 thousand monthly visits. Genexa offers products and services including Acetaminophen Extra Strength, Cough & Chest Congestion, and Allergy Care. Its focus areas include Traditional Pharmaceuticals, Generics and OTC Drugs. Its legal entity is GENEXA INC.
Company details
Genexa was founded in 2014 and is based in Beverly Hills, United States. Nutraceutical products are produced for sleep, stress, cold, flu, digestive health, and pain relief, targeting both adults and children. These are offered in sprays, liquid drops, and tablets, with USDA certification and non-GMO verification applied to all items. Operations focus on clean ingredient sourcing within the health and wellness sector.
- Headquarters Beverly Hills, United States
- Employees 23
- Founders David Johnson
- SectorsHealthcare
- Email••••••••
- Website genexa.com
- Social LinkedIn X Facebook Instagram
- Legal Name Genexa Inc.
- Total Equity Funding$60M (USD)
in 2 rounds
- InvestorsNorth Castle Partners
& 22 more
- Employee Count23
Products & Services of Genexa
Genexa offers a comprehensive portfolio of products and services, including Acetaminophen Extra Strength, Cough & Chest Congestion, and Allergy Care.
Provides pain and fever relief without artificial additives.
Relieves cough and congestion symptoms with clean ingredients.
Manages allergy symptoms using effective, additive-free formulas.
Funding Insights of Genexa
Genexa has successfully raised a total of $60M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $60M
- Total Rounds 2
- First Round $60M
(Jul 2021)
- Investors Count 23
All 2 funding rounds of Genexa with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2023 | Angel Round | – | Nikki Reed | – | |
| Jul 2021 | $60M | Series A | – | Monogram Capital Partners |
23 investors in total: 6 institutional and 17 angel.
Investors in Genexa
Genexa has secured backing from 23 investors, including angel and venture fund investors. Prominent investors backing the company include North Castle Partners, Nikki Reed and Platinum Mile Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment services are provided for disruptive global businesses. | platinummileventures.com | |||
PE firm invests in the US | monogramcapital.com | Beverly Hills, United States | ||
Corporate-backed venture capital firm focused on consumer tech and multiple sectors | unileverventures.com | London, United Kingdom | ||
US private equity investments are managed by North Castle Partners. | 1997 | northcastlepartners.com | Greenwich, United States | |
Single family office of a Belgian family focused on multiple industries | verlinvest.com | Brussels, Belgium | ||
Long-term growth equity is provided to global consumer companies. | 2021 | pointkingcapital.com | Sydney, Australia | |
NR Nikki Reed | unknown_d2d3baab75c54eaea | |||
CP Chris Pratt | unknown_3613398d216647df8 | |||
KS Katherine Schwarzenegger | unknown_f8c31040f76d4aae8 | |||
GP Gwyneth Paltrow | unknown_43e84ddbe13d4179b |
Investor details for Genexa
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Genexa
20 people are tracked at Genexa (9 in leadership, 3 in board & advisors, 8 in team); the tracked headcount is 23.
| Name | Role | Group |
|---|---|---|
David Johnson | Founder & CEO | Leadership |
Emily Hazlett | Sr. Director, Brand Marketing | Leadership |
Carmen Graham | Chief Marketing Officer | Leadership |
Tianna Johnston, MHA | Director Of Operations | Leadership |
Arik Johnson | VP, Sales | Leadership |
Max Spielberg | President | Leadership |
Michael McKinnon | Senior Director of Sales | Leadership |
Craig R. Williams | Chief Of Staff | Leadership |
Ana Silva | Chief Financial Officer | Leadership |
Taz Bhatia | Advisor | Board & advisors |
Alejandro Junger | Advisor | Board & advisors |
Kellyann Petrucci | Advisor | Board & advisors |
Rebecca K. | Senior Quality Manager | Team |
Brooke Bahorich | Sales Coordinator | Team |
Shelby Halley | Project Manager | Team |
Julia Shedlin | Customer Service Manager | Team |
Mehak Ali | Senior Accountant | Team |
Daniel Rosenberg | Compliance Manager | Team |
Jennifer Carroll | Sales Operations Specialist | Team |
Taryn Fixel | Advisor | Team |
Complete people profiles for Genexa
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Genexa
3 dated milestones of Genexa across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Genexa is founded.
- Funding First funding round of $60.0M.
- Funding Latest funding round, Angel Round,.
Web traffic of Genexa
The website of Genexa (genexa.com) receives about 43.4K visits a month.
- Monthly visits43.4K
▼ 12.8% vs previous month
Websites whose visitors overlap most with Genexa. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
sinussnoringent.com | sinussnoringent.com | 100% | #2,513,620 | – | |
| natrol.com | 86% | 90K | #439,586 | View details | |
ashcroftpharmacy.co.uk | ashcroftpharmacy.co.uk | 86% | #188,549 | – | |
metagenics.com.au | metagenics.com.au | 86% | – | ||
| theindependentpharmacy.co.uk | 69% | #67,572 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Genexa
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Genexa (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genexa
Complete news archive for Genexa
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genexa
Genexa was founded in 2014 and raised its 1st funding round 7 years after it was founded.
Genexa is headquartered in Beverly Hills, United States. It is registered at Beverly Hills, California, United States.
David Johnson is the CEO of Genexa, as recorded in our data. They have also founded this company.
Genexa is a funded company, having raised a total of $60M across 2 funding rounds to date. The company's 1st funding round was a Series A of $60M, raised on Jul 2021.
Genexa has 23 employees.
Genexa was founded in 2014 and is based in Beverly Hills, United States. Nutraceutical products are produced for sleep, stress, cold, flu, digestive health, and pain relief, targeting both adults and children. These are offered in sprays, liquid drops, and tablets, with USDA certification and non-GMO verification applied to all items. Operations focus on clean ingredient sourcing within the health and wellness sector.
Genexa offers Acetaminophen Extra Strength, Cough & Chest Congestion, and Allergy Care.
Genexa has 23 investors. Key investors include North Castle Partners, Nikki Reed, Platinum Mile Ventures, Monogram Capital Partners, and Unilever Ventures.
Genexa operates through Genexa Inc..